A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy.
Vaccination is a proven strategy to mitigate morbidity and mortality of infectious diseases. The methodology of identifying and testing new vaccine candidates could be improved with rational design and in vitro testing prior to animal experimentation. The tularemia vaccine, Francisella tularensis li...
Main Authors: | Deanna M Schmitt, Dawn M O'Dee, Joseph Horzempa, Paul E Carlson, Brian C Russo, Jacqueline M Bales, Matthew J Brown, Gerard J Nau |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3280287?pdf=render |
Similar Items
-
Global transcriptional response to mammalian temperature provides new insight into <it>Francisella tularensis </it>pathogenesis
by: Shanks Robert MQ, et al.
Published: (2008-10-01) -
The use of resazurin as a novel antimicrobial agent against Francisella tularensis
by: Deanna Marie Schmitt, et al.
Published: (2013-12-01) -
A predicted Francisella tularensis DXD-motif glycosyltransferase blocks immune activation
by: Gerard J. Nau, et al.
Published: (2019-01-01) -
Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development
by: Lydia M. Roberts, et al.
Published: (2018-04-01) -
Developing a DNA vaccine against francisella tularensis
by: Al-Shamisi, Mariam Bakhit Salem
Published: (2003)